ContextVision Feed

2026-03-06 20:48:00 ContextVision AB: Transactions made under the buy-back programme

2026-03-02 07:30:00 ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO 2,97 NOK | -1,00% | 0,28 MNOK

2026-02-25 17:04:00 ContextVision AB: Transactions made under the buy-back programme 2,97 NOK | -6,01% | 0,49 MNOK

2026-02-19 10:02:08 CONTX: Financial calendar 3,48 NOK | +5,45% | 0,09 MNOK

2026-02-19 08:00:00 ContextVision AB: Year-end report 2025 – Substantial progress in transformation amid early signs of stabilization 3,48 NOK | +5,45% | 0,09 MNOK

2026-02-18 16:50:00 ContextVision announces extended share buy-back programme 3,48 NOK | +5,45% | 0,09 MNOK

2026-02-16 17:16:00 ContextVision AB: Transactions made under the buy-back programme 3,21 NOK | +0,63% | 0,03 MNOK

2026-02-05 17:00:00 ContextVision AB: Transactions made under the buy-back programme 3,77 NOK | +1,89% | 0,06 MNOK

2026-01-27 17:17:00 ContextVision AB: Transactions made under the buy-back programme 3,80 NOK | +0,26% | 0,03 MNOK

2026-01-16 17:26:00 ContextVision AB: Transactions made under the buy-back programme

2026-01-07 18:36:00 ContextVision AB: Transactions made under the buy-back programme 3,87 NOK | -1,78% | 0,19 MNOK

2025-12-22 17:25:00 ContextVision AB: Transactions made under the buy-back programme 4,19 NOK | -2,56% | 0,22 MNOK

2025-12-11 17:08:00 ContextVision AB: Transactions made under the buy-back programme 3,99 NOK | 0,00% | 0,22 MNOK

2025-12-10 13:08:00 ContextVision initiates the clinical phase of its point-of-care ultrasound innovation venture to advance liver disease diagnostics 4,29 NOK | +10,85% | 0,15 MNOK

2025-12-02 18:45:00 ContextVision AB: Transactions made under the buy-back programme 3,96 NOK | +0,51% | 0,05 MNOK

2025-12-01 11:25:50 CONTX: Financial calendar 4,04 NOK | -3,12% | 0,17 MNOK

2025-11-21 17:10:00 ContextVision AB: Transactions made under the buy-back programme

2025-11-12 17:11:00 ContextVision AB: Transactions made under the buy-back programme 3,78 NOK | -0,53% | 0,10 MNOK

2025-11-06 08:00:00 ContextVision AB: Q3 interim report 2025 – Navigating market uncertainty while making solid progress with our Data Quality initiative 3,85 NOK | -13,48% | 0,89 MNOK

2025-11-03 16:50:00 ContextVision AB: Transactions made under the buy-back programme 4,35 NOK | +0,46% | 0,03 MNOK

2025-10-23 17:08:00 ContextVision AB: Transactions made under the buy-back programme 4,50 NOK | +0,22% | 0,07 MNOK

2025-10-14 17:50:00 ContextVision AB: Transactions made under the buy-back programme 4,49 NOK | -0,22% | 0,20 MNOK

2025-10-03 19:45:00 ContextVision AB: Transactions made under the buy-back programme

2025-09-24 18:00:00 ContextVision AB: Transactions made under the buy-back programme 4,50 NOK | +0,22% | 0,21 MNOK

2025-09-15 18:00:00 ContextVision AB: Transactions made under the buy-back programme 4,66 NOK | +2,87% | 0,11 MNOK

2025-09-03 09:00:00 ContextVision - Initiation of share buyback program 4,59 NOK | +10,87% | 1,04 MNOK

2025-08-26 08:00:12 CONTX: ContextVision publishes Webcast for the Q2 report 2025 4,56 NOK | 0,00% | 0,64 MNOK

2025-08-26 08:00:00 ContextVision AB: Delårsrapport Q2 2025 - Kunder pressade av handelsosäkerhet – vi fortsätter investera för att bygga morgondagens lösningar 4,56 NOK | 0,00% | 0,64 MNOK

2025-08-26 08:00:00 ContextVision publishes Webcast for the Q2 report 2025 4,56 NOK | 0,00% | 0,64 MNOK

2025-08-26 08:00:00 ContextVision AB: Q2 interim report 2025 – Customers pressured by trade uncertainty – We continue to invest to build tomorrow’s solutions 4,56 NOK | 0,00% | 0,64 MNOK

2025-05-30 08:00:11 CONTX: ContextVision och AMRA Medical inleder samarbete för att förbättra multimodal bilddiagnostik vid leversjukdomar 4,90 NOK | +1,87% | 0,02 MNOK

2025-05-30 08:00:10 CONTX: ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics 4,90 NOK | +1,87% | 0,02 MNOK

2025-05-30 08:00:00 ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics 4,90 NOK | +1,87% | 0,02 MNOK

2025-05-30 08:00:00 ContextVision och AMRA Medical inleder samarbete för att förbättra multimodal bilddiagnostik vid leversjukdomar 4,90 NOK | +1,87% | 0,02 MNOK

2025-05-13 15:45:00 BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL) 4,61 NOK | -2,89% | 0,45 MNOK

2025-05-13 15:45:00 KOMMUNIKÉ FRÅN ÅRSSTÄMMA I CONTEXTVISION AB (PUBL) 4,61 NOK | -2,89% | 0,45 MNOK

2025-05-07 08:00:14 CONTX: ContextVision publishes Webcast for the Q1 report 2025 4,90 NOK | -19,67% | 1,10 MNOK

2025-05-07 08:00:00 ContextVision publishes Webcast for the Q1 report 2025 4,90 NOK | -19,67% | 1,10 MNOK

2025-05-07 08:00:00 ContextVision AB: Q1 interim report 2025 – Executing on our strategy for Image Quality and Data Quality 4,90 NOK | -19,67% | 1,10 MNOK

2025-04-11 09:30:00 NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL) 5,70 NOK | 0,00% | 0,13 MNOK

2025-04-11 09:30:00 ContextVision publishes annual report for the fiscal year 2024 5,70 NOK | 0,00% | 0,13 MNOK

2025-04-11 09:30:00 ContextVision publicerar årsredovisning för verksamhetsåret 2024 5,70 NOK | 0,00% | 0,13 MNOK

2025-04-11 09:30:00 KALLELSE TILL ÅRSSTÄMMA I CONTEXTVISION AB (PUBL) 5,70 NOK | 0,00% | 0,13 MNOK

2025-04-07 08:00:06 CONTX: ContextVision partners with University of Waterloo in Canada and InPhase Solutions AS in Norway to advance ultrasound diagnostics for MASLD 5,50 NOK | -3,51% | 0,35 MNOK

2025-04-07 08:00:05 CONTX: ContextVision i samarbete med University of Waterloo i Kanada och InPhase Solutions AS i Norge för att driva utvecklingen av ultraljudsdiagnostik vid MASLD 5,50 NOK | -3,51% | 0,35 MNOK

2025-02-20 08:00:04 CONTX: ContextVision publishes Webcast for the Year-end Report 2024 6,10 NOK | -1,93% | 1,45 MNOK

2025-02-20 08:00:00 ContextVision AB: Year-end Report 2024 – Progress in Data Quality and growing interest 6,10 NOK | -1,93% | 1,45 MNOK

2025-02-20 08:00:00 ContextVision publishes Webcast for the Year-end Report 2024 6,10 NOK | -1,93% | 1,45 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

ContextVision

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden